The CTRB1/2 locus affects diabetes susceptibility and treatment via the incretin pathway

MLA

t Hart, L. M., et al. “The CTRB1/2 Locus Affects Diabetes Susceptibility and Treatment via the Incretin Pathway.” Diabetes Vol.62 (2013) Nr.9 p.3275-3281 [ISSN 0012-1797], 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn931049884&authtype=sso&custid=ns315887.

APA

t Hart, L. M., Fritsche, A., Nijpels, G., van Leeuwen, N., Donnelly, L. A., Dekker, J. M., Alssema, M., Fadista, J., Carlotti, F., Gjesing, A. P., Palmer, C. N., van Haeften, T. W., Herzberg-Schafer, S. A., Simonis-Bik, A. M., Houwing-Duistermaat, J. J., Helmer, Q., Deelen, J., Guigas, B., Hansen, T., … Diamant, M. (2013). The CTRB1/2 locus affects diabetes susceptibility and treatment via the incretin pathway. Diabetes Vol.62 (2013) Nr.9 p.3275-3281 [ISSN 0012-1797].

Chicago

t Hart, L.M., A. Fritsche, G. Nijpels, N. van Leeuwen, L.A. Donnelly, J.M. Dekker, M. Alssema, et al. 2013. “The CTRB1/2 Locus Affects Diabetes Susceptibility and Treatment via the Incretin Pathway.” Diabetes Vol.62 (2013) Nr.9 p.3275-3281 [ISSN 0012-1797]. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn931049884&authtype=sso&custid=ns315887.